Clinical Trials Directory

Trials / Unknown

UnknownNCT02321189

The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
23 Years – 28 Years
Healthy volunteers
Accepted

Summary

Choroidal thickness represents blood-flowing of eyes. The investigators detect the choroidal thickness of the young participant using SD-OCT to see the effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness.

Detailed description

34 young, healthy participants were included in this study; They were randomly divided into two groups by age and gender matched.100 mg Longevinex® capsule was given to the study group and 100mg placebo capsule to the control group. All participants underwent OCT scanning with spectral domain optic coherence tomography (SD-OCT) at baseline and 1 h following Longevinex® or placebo administration. The choroidal thickness was measured manually by the Heidelberg Eye explore software(version 5.3.3.0, Heidelberg Engineering) with a vertical line to the retinal pigment epithelial layer.

Conditions

Interventions

TypeNameDescription
DRUGLONGEVINEXlet everyone of the participants oral 1 capsule containing 100 mg LONGEVINEX
DRUGplacebolet everyone of the participants oral 1 capsule containing 100 mg placebo

Timeline

Start date
2014-10-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-12-22
Last updated
2015-04-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02321189. Inclusion in this directory is not an endorsement.